The Global Cell And Gene Therapy Market Report by The Business Research Company covers cell and gene therapy market drivers and restraints, cell and gene therapy market size, major players, and the impact of COVID-19 on the cell and gene therapy market.
The cell and gene therapy market consist of sales of cell and gene therapies by entities (organizations, sole traders and partnerships) that develop cell and gene therapies. Cell therapy refers to the transfer of intact, live cells that are originated from autologous or allogenic sources and gene therapy refers to the introduction, removal, or change in the genome for treating diseases. The market consists of revenue generated by the companies developing cell and gene therapy products by the sales of these products.
Steady investment and consolidation in cell and gene therapies contributed to the growth of the cell and gene therapy (CGT) market. The global cell and gene therapy market is expected to grow from $6.69 billion in 2020 to $7.96 billion in 2021 at a compound annual growth rate (CAGR) of 19%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The cell and gene therapy market is expected to reach $17.32 billion in 2025 at a CAGR of 21%.
Request A Sample For The Global Cell And Gene Therapy Market Report:
Some cell and gene therapy market trends include chimeric antigen receptor (CAR) T-cell therapy. CAR T-cell therapy is a combination of cell and gene therapy in which T cells are collected from the patient’s blood and are genetically engineered to produce modified receptors at their surface, known as chimeric antigen receptors (CARs). These modified T cells with special structures (receptors) are reinfused into the patient. Then, the modified receptors of T cell help in targeting the surface antigen of the cancer cell that ultimately results in the killing of tumor cells in patients.
Global cell and gene therapy market segments include:
1) By Product: Cell Therapy, Gene Therapy.
2) By Application: Oncology, Dermatology, Musculoskeletal, Others.
3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Others.
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Cell and Gene Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030 At:
The Cell and Gene Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides cell and gene therapy market overviews, analyzes and forecasts market size, share, cell and gene therapy market players, cell and gene therapy market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The cell and gene therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Cell and Gene Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries.
Market Players Covered: Gilead Sciences, Bristol-Myers Squibb, Novartis AG, Amgen, Merck, Organogenesis Holdings, Dendreon, Variceal, Bluebird Bio, Fibrocell Science, Biogen, Pfizer, ViroMed, Advantagene, Advaxis, Alnylam Pharmaceuticals.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The Cell And Gene Therapy Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The Cell And Gene Therapy Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the Cell And Gene Therapy Global Market Report 2021: